Parasites & Vectors, 2018 Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas
Nadja Rohdich +6 more
doaj +1 more source
Flea and tick treatment satisfaction, preference and adherence of dog owners in the United States, United Kingdom and Australia who treated their dog with fluralaner [PDF]
Open Veterinary Journal, 2020 Background: An extended duration flea and tick medication of the isoxazoline class (fluralaner) was introduced in 2014 in the United States and other countries.
Robert Lavan +4 more
doaj +1 more source
Selection of new chemicals to be used in conditioned aversion for non-lethal predation control [PDF]
, 2019 Globally, native predators and scavengers are threatened through the incidence of illegal poisoning due to increasing human-wildlife conflicts. The use of conditioned taste aversion (CTA) may mitigate such conflicts.
Ferreras, Pablo +6 more
core +1 more source
Feline Atopic Skin Syndrome: an Introduction to Recently Proposed Terminology and How to Work Up the Case [PDF]
, 2023 Atopic disease remains as an enigmatic hypersensitivity disorder in feline patients. Studies of cutaneous atopic syndrome in cats have reported several reaction patterns in cats, presenting as a diagnostic challenge, and a recent literature review has ...
Gunawan, Michael +2 more
core +2 more sources
Efficacy of three consecutive monthly doses of a topical formulation of selamectin and sarolaner (Revolution\u3csup\u3e®\u3c/sup\u3e Plus/Stronghold\u3csup\u3e®\u3c/sup\u3e Plus) compared with a single dose of fluralaner (Bravecto\u3csup\u3e®\u3c/sup\u3e for Cats) against induced infestations of Ctenocephalides felis on cats [PDF]
, 2019 In a controlled laboratory study, the efficacy against fleas, Ctenocephalides felis, of a single treatment of fluralaner topical solution (Bravecto® for Cats, Merck) was compared with that of three consecutive monthly topical treatments with selamectin ...
Chapin, Sara +3 more
core +1 more source
Parasites & Vectors, 2015 Background Fluralaner is a novel isoxazoline eliciting both acaricidal and insecticidal activity through potent blockage of GABA- and glutamate-gated chloride channels.
Heike Williams +4 more
doaj +1 more source
Acaricidal Activity Of The Orally Administered Isoxazoline Drugs (lotilaner, Fluralaner, And Afoxolaner) In White-Footed Mice Against Larval Ticks [PDF]
, 2023 Lyme disease, caused by Borrelia burgdorferi, is currently the most prevalent vector borne disease in North America. With the CDC estimating almost 500,000 new cases every year, methods are needed to control the vector, the black legged tick (Ixodes ...
Gisi, Emily Marie
core +1 more source
Parasites & Vectors, 2014 Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical ...
Feli M Walther +4 more
doaj +1 more source
The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod γ-aminobutyric acid- and l-glutamate-gated chloride channels and insecticidal/acaricidal activity [PDF]
, 2014 Isoxazolines are a novel class of parasiticides that are potent inhibitors of γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and l-glutamate-gated chloride channels (GluCls).
Gassel, Michael +4 more
core +1 more source
Environmental Toxicity Of Isoxazoline Drugs On Non-Target Species [PDF]
, 2023 Lyme disease affects tens of thousands of people every year in the United States, causing serious illness and even death. It is caused by the bacterium, Borrelia burgdorferi, through infected black-legged tick bites. The range of these ticks is expanding,
Cooper, Haley M
core +1 more source